- Summary and Literature Review of Parion Sciences’ Drug Pipeline
- The Concomitant Use of (1) Aminoglycoside Antibiotics (Gentamicin, Amikacin and Tobramycin) and (2) Kalydeco® (VX-770) in F508del/G542X Heterozygous Individuals with Cystic Fibrosis May Increase Readthrough of the G542X Premature Stop Codon and Potentiate the Functional G542X Containing CFTR Protein at the Apical Cell Membrane
